PHIOPhio Pharmaceuticals Corp.vs its industry peers
A metric-by-metric comparison of Phio Pharmaceuticals Corp. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHIO본 종목 | $12M#7 | — | 0.9x#2 | — | -100.0%#5 | -21.7%#7 | — | -69.0%#2 | — | — | -51.9%#1 | — |
| LSTA | $14M#2 | — | 1.7x#7 | 81.1x#4 | -83.0%#4 | 17.0%#5 | -10711.2%#4 | -201.2%#5 | — | 3#2 | — | — |
| SCNX | $14M#3 | — | 0.2x#1 | 31.9x#2 | 215.9%#1 | -404.5%#11 | -9867.9%#3 | -64.8%#1 | -73.5%#1 | 4#1 | — | 108.0%#1 |
| ADIL | $14M#4 | — | — | — | — | 39.5%#2 | — | — | — | — | — | — |
| PPCB | $48M#1 | 0.0x#1 | 4.9x#8 | — | — | -3136.6%#13 | — | -599.6%#9 | -533.3%#2 | — | — | — |
| AEON | $13M#5 | — | — | — | — | -193.4%#10 | — | — | — | — | — | — |
| BIVI | $13M#6 | — | 1.3x#4 | — | — | -25.8%#9 | — | -214.9%#7 | -1671.2%#3 | — | — | — |
| ASBP | $11M#9 | 0.0x#2 | 1.0x#3 | 1827.3x#5 | — | -1768.9%#12 | -312016.9%#5 | -208.2%#6 | — | — | — | — |
| TPST | $11M#8 | — | — | 38.6x#3 | -54.8%#3 | 37.2%#4 | -9008.5%#2 | — | — | — | -92.3%#2 | — |
| LIPO | $11M#10 | — | 7.1x#9 | 19.8x#1 | 19.3%#2 | -8.6%#6 | -947.2%#1 | -337.2%#8 | — | — | — | — |
| AZTR | $11M#11 | 8.7x#3 | 1.4x#5 | — | -100.0%#5 | -22.2%#8 | — | -149.4%#3 | — | — | — | — |
| BPTH | $11M#12 | — | — | — | -100.0%#5 | 38.5%#3 | — | — | — | — | — | — |
| MTVA | $11M#13 | — | 1.5x#6 | — | — | 53.0%#1 | — | -190.2%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice